MC-001

N/A

Report date: 2025/03/25 16:00:22

Base Information

Drug NameMC-001
Drug Alias NameUCBMNCUCBAllogeneic human umbilical cord blood monocyte therapyAllogeneic human leukocyte antigen (HLA)-matched umbilical cord blood mononuclear stem cellsUmbilical cord blood mononuclear cells +[8] 
ClassificationCell and gene therapy > Cell therapy > Donor > AllogeneicCell and gene therapy > Cell therapy > Stem cell therapy > Hematopoietic stem cells therapyCell and gene therapy > Cell therapy > Immune system cell therapy > Leukocyte cell therapy > Monocyte cell therapy +[4] 
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsIschemic StrokeSpinal Cord InjuriesCerebral Palsy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesTaiwan
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesStemcyte Inc
China Registration ClassN/A

Develop Information

Active CompaniesStemcyte Inc
Inactive CompaniesN/A
Active IndicationsIschemic StrokeSpinal Cord InjuriesCerebral Palsy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A